Buy Now over-the-counter products
How to Prescribe
Contact Us

About Company

Our mission: To provide a smarter way to relieve severe pain
immediately with deep and long-lasting results.

Our story

BioWave® is a non-opioid, FDA cleared, patented, Smarter Pain Blocking Technology® designed to block pain at the source. We offer a comprehensive approach to personalized care focused on outcomes for each patient. Our technology is safe and effective with no drugs and no side effects. It is portable and easy to use with one-button control. BioWave® products are widely prescribed to people with acute, chronic and post-operative pain.

History

BioWave’s proprietary technology was developed and born in professional sports in conjunction with the New York Giants football team through a clinical study treating pain from acute and chronic injuries in professional football players. This study and others were the basis for our first FDA clearance.
After getting its first FDA clearance, BioWave built a strong customer base in professional, collegiate, and Olympic sports which continues to this day. Professional & Collegiate Athletic trainers consider BioWave a go-to modality to help their athletes manage pain through their recovery and rehabilitation from sports related injuries. In 2017 BioWave began helping patients of the Veterans Administration, Department of Labor and Active Military manage their acute and chronic pain conditions. To date BioWave has been prescribed by over 140 Federal Healthcare VA Сlinics resulting in a number of white papers and a published study that document successful outcomes for patients who used BioWave. BioWave’s prescription products have been prescribed to over 500 professional athletes and are used by over 105 professional sports teams in the NFL, MLB, NBA, NHL and MLS and by over 140 college sports teams.

Leadership

Rob Adler

Chairman

Bradford Siff

Founder & President

Rob Wolter

Chief Executive Officer

Joseph Papandrea

Chief Revenue Officer

Management

Tom Keating

Director of Finance

Tia Cavone

Senior Director of Operations

Renee Cody

Senior Director of Corporate Development

Ania Kuniej

Director of Marketing

Tony Queiroga

Senior Director of Government Sales

Tijana Radinkovic

Director of Customer Service

BioWave is Changing
Lives every day

Fill Out The Form

Contact Us
Buy Now over-the-counter products

Phone: 1-877-BIOWAVE (1-877-246-9283)

Fax: (475) 444-3400

For Inquiries: info@biowave.com

Support: support@biowave.com

BioWave Corporation8 Knight Street,
Suite 201 Norwalk, CT 06851

EMEA Partner

Rob Adler

Chairman

Rob is the Managing Partner of Northstar Pain Management LLC. Northstar acquired a controlling interest in Biowave in December 2015. He is Chairman of the Board of Directors of BioWave.

Rob joined the Company in 2016, bringing with him decades of Wall Street experience.  He has served as President to XTF Advisors, an ETF Research and Trading firm in New York City, and President to AmStar Funds and National Funds, a Broker/Dealer, in his previous roles.  He was Co-Founder of NorthStar Investment Management Corp (now part of Voya Investment Management, and formerly known as ING Funds), and also spent many years as a Senior Vice President at Shearson/Lehman Brothers.  Rob holds a B.A. in History from State University of New York Purchase College, and an MBA from the NYU Stern School of Business.

Brad Siff

Founder & President

Brad is the founder of BioWave and a member of the Board of Directors. He is a skilled business leader and provides the guiding vision and strategic direction for the company. Brad manages new product development, R&D, clinical studies and applications, reimbursement strategy, quality, regulatory, contract manufacturing, government affairs and corporate finance. His original concept for BioWave’s signal technology came from an inspiration he had while working as the Chief Operating Officer at a prior medical device company. Brad also worked for 7 years as Senior Vice President of Mergers & Acquisitions for Daiwa Securities with a focus on the Medical Device Industry.

Brad received undergraduate and Master’s degrees from Cornell Engineering and an MBA from Cornell’s Johnson Graduate School of Management. Brad’s Master’s Thesis was focused on a project for the Hospital for Special Surgery in New York City. In his spare time, Brad is a fitness junkie and has been known to rip tremendous topspin on a tennis or paddle ball. He is an artist, photographer, and fond of traveling, skiing, food and wine.